These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38242283)

  • 1. Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation and Promote T-helper 1 Development in Newborns, Adults and Elders.
    Thomas S; Pak J; Doss-Gollin S; Ryff K; Beijnen E; Pedersen GK; Christensen D; Levy O; van Haren SD
    J Mol Biol; 2024 Feb; 436(4):168446. PubMed ID: 38242283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses.
    Yang JX; Tseng JC; Tien CF; Lee CY; Liu YL; Lin JJ; Tsai PJ; Liao HC; Liu SJ; Su YW; Hsu LC; Chen JK; Huang MH; Yu GY; Chuang TH
    Int J Biol Sci; 2023; 19(9):2897-2913. PubMed ID: 37324951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization.
    van Haren SD; Dowling DJ; Foppen W; Christensen D; Andersen P; Reed SG; Hershberg RM; Baden LR; Levy O
    J Immunol; 2016 Dec; 197(11):4413-4424. PubMed ID: 27793997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR agonist combinations that stimulate Th type I polarizing responses from human neonates.
    Surendran N; Simmons A; Pichichero ME
    Innate Immun; 2018 May; 24(4):240-251. PubMed ID: 29673285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination.
    Hayashi T; Momota M; Kuroda E; Kusakabe T; Kobari S; Makisaka K; Ohno Y; Suzuki Y; Nakagawa F; Lee MSJ; Coban C; Onodera R; Higashi T; Motoyama K; Ishii KJ; Arima H
    Front Immunol; 2018; 9():2619. PubMed ID: 30515151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant.
    van Haren SD; Ganapathi L; Bergelson I; Dowling DJ; Banks M; Samuels RC; Reed SG; Marshall JD; Levy O
    Cytokine; 2016 Jul; 83():99-109. PubMed ID: 27081760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
    Ho NI; Huis In 't Veld LGM; Raaijmakers TK; Adema GJ
    Front Immunol; 2018; 9():2874. PubMed ID: 30619259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucoidan can function as an adjuvant in vivo to enhance dendritic cell maturation and function and promote antigen-specific T cell immune responses.
    Jin JO; Zhang W; Du JY; Wong KW; Oda T; Yu Q
    PLoS One; 2014; 9(6):e99396. PubMed ID: 24911024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
    Krumbiegel D; Zepp F; Meyer CU
    Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses.
    Mori A; Oleszycka E; Sharp FA; Coleman M; Ozasa Y; Singh M; O'Hagan DT; Tajber L; Corrigan OI; McNeela EA; Lavelle EC
    Eur J Immunol; 2012 Oct; 42(10):2709-19. PubMed ID: 22777876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
    Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
    J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells.
    Lemoine S; Jaron B; Tabka S; Ettreiki C; Deriaud E; Zhivaki D; Le Ray C; Launay O; Majlessi L; Tissieres P; Leclerc C; Lo-Man R
    J Allergy Clin Immunol; 2015 Nov; 136(5):1355-68.e1-15. PubMed ID: 25865351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.
    Temizoz B; Kuroda E; Ohata K; Jounai N; Ozasa K; Kobiyama K; Aoshi T; Ishii KJ
    Eur J Immunol; 2015 Apr; 45(4):1159-69. PubMed ID: 25529558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
    Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O
    J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-Induced CD8
    Beijnen EMS; van Haren SD
    Front Immunol; 2020; 11():607977. PubMed ID: 33424857
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Kim WS; Han JM; Song HY; Byun EH; Lim ST; Byun EB
    Nutrients; 2020 May; 12(6):. PubMed ID: 32486094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
    Tada H; Aiba S; Shibata K; Ohteki T; Takada H
    Infect Immun; 2005 Dec; 73(12):7967-76. PubMed ID: 16299289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of early and rapid type I IFN, IL-1α, and IL-1β production are essential mediators of RNA-like adjuvant driven CD4+ Th1 responses.
    Madera RF; Wang JP; Libraty DH
    PLoS One; 2011; 6(12):e29412. PubMed ID: 22206014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
    Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
    Front Immunol; 2021; 12():786144. PubMed ID: 35095862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.